Chemours Balance Sheet

CC / Materials|13 years of annual SEC 10-K data (FY2013-FY2025)

Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.

Chemours had $7.4B in total assets and $566M in shareholders' equity as of FY2025. Total debt was $4.1B against $670M in cash, resulting in $3.4B net debt.

Based on SEC 10-K filings.

Key Data Points

Altman Z-Score NaN (distress zone, below 1.23 threshold)
Currently unprofitable: Net income is negative
Cash-backed earnings: Operating cash flow exceeds net income
High leverage: Debt-to-equity ratio of 7.19

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Cash & Equivalents	$670.0M	$713.0M	$1.2B	$1.1B	$1.5B	$1.1B	$943.0M	$1.2B	$1.6B	$902.0M	$366.0M	$0	$0
Accounts Receivable	$562.0M	$619.0M	$509.0M	$509.0M	$644.0M	$449.0M	$602.0M	$790.0M	$847.0M	$742.0M	$757.0M	$746.0M	-
Inventory	$1.6B	$1.5B	$1.3B	$1.4B	$1.1B	$939.0M	$1.1B	$1.1B	$935.0M	$767.0M	$972.0M	$1.1B	-
Current Assets	$3.0B	$3.0B	$3.8B	$3.2B	$3.3B	$2.6B	$2.8B	$3.3B	$3.5B	$2.6B	$2.3B	$1.9B	-
PP&E (Net)	$3.1B	$3.2B	$3.2B	$3.2B	$3.2B	$3.5B	$3.6B	$3.3B	$3.0B	$2.8B	$3.2B	$3.3B	$3.0B
Goodwill	$46.0M	$46.0M	$102.0M	$102.0M	$102.0M	$153.0M	$153.0M	-	$153.0M	$153.0M	$166.0M	$198.0M	$198.0M
Total Assets	$7.4B	$7.5B	$8.2B	$7.6B	$7.5B	$7.1B	$7.3B	$7.4B	$7.3B	$6.1B	$6.3B	$6.0B	-
Current Liabilities	$1.7B	$1.8B	$2.5B	$1.9B	$1.9B	$1.4B	$1.5B	$1.7B	$1.6B	$1.8B	$1.5B	$1.4B	-
Total Debt	$4.1B	$4.1B	$4.0B	$3.6B	$3.7B	$4.0B	$4.0B	$4.0B	$4.1B	$3.6B	$4.0B	$0	-
Shareholders' Equity	$566.0M	$571.0M	$721.0M	$1.1B	$1.1B	$813.0M	$689.0M	$1.0B	$860.0M	$100.0M	$126.0M	$3.7B	$3.2B

Other Financial Statements

Income Statement Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Chemours Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

Cash & Equivalents

$670.0M

$713.0M

$1.2B

$1.1B

$1.5B

$1.1B

$943.0M

$1.2B

$1.6B

$902.0M

$366.0M

Accounts Receivable

$562.0M

$619.0M

$509.0M

$644.0M

$449.0M

$602.0M

$790.0M

$847.0M

$742.0M

$757.0M

$746.0M

Inventory

$1.6B

$1.5B

$1.3B

$1.4B

$1.1B

$939.0M

$1.1B

$935.0M

$767.0M

$972.0M

$1.1B

Current Assets

$3.0B

$3.8B

$3.2B

$3.3B

$2.6B

$2.8B

$3.3B

$3.5B

$2.6B

$2.3B

$1.9B

PP&E (Net)

$3.1B

$3.2B

$3.5B

$3.6B

$3.3B

$3.0B

$2.8B

$3.2B

$3.3B

$3.0B

Goodwill

$46.0M

$102.0M

$153.0M

$166.0M

$198.0M

Total Assets

$7.4B

$7.5B

$8.2B

$7.6B

$7.5B

$7.1B

$7.3B

$7.4B

$7.3B

$6.1B

$6.3B

$6.0B

Current Liabilities

$1.7B

$1.8B

$2.5B

$1.9B

$1.4B

$1.5B

$1.7B

$1.6B

$1.8B

$1.5B

$1.4B

Total Debt

$4.1B

$4.0B

$3.6B

$3.7B

$4.0B

$4.1B

$3.6B

$4.0B

Shareholders' Equity

$566.0M

$571.0M

$721.0M

$1.1B

$813.0M

$689.0M

$1.0B

$860.0M

$100.0M

$126.0M

$3.7B

$3.2B